NCT03655899

Metabolomic Alterations in the Vascular Compartment in Patients With Sepsis

Metabolomic Alterations in the Vascular Compartment in Patients With Sepsis - an Observational Study
Pär Johansson·ClinicalTrials.govTerminated
View on ClinicalTrials.gov
Study focus
Disease/Condition
Endothelial Dysfunction
Study type
Observational
Sponsor & location
Primary sponsor
Pär Johansson
Funder
Rigshospitalet, Denmark
Location
Copenhagen, Denmark
Timeline & enrollment
Phase
N/A
Start date
Oct 23, 2017
End date
Mar 12, 2019
Enrollment
37 participants
Primary outcome

Shock induced endotheliopaty

Summary

This study will investigate the metabolic alterations of vascular cells caused by sepsis and
 septic shock

ICD-10 classifications
Other peripheral vascular diseasesAtherosclerosis of arteries of extremitiesOther specified peripheral vascular diseasesRenovascular hypertensionOther disorders of arteries and arterioles
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03655899
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03655899 through Pure Global AI's free database. This phase not specified trial is sponsored by Pär Johansson and is currently Terminated. The study focuses on Endothelial Dysfunction. Target enrollment is 37 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.